Prestige V + VEE with Havlogen

This page contains information on Prestige V + VEE with Havlogen for veterinary use.
The information provided typically includes the following:
  • Prestige V + VEE with Havlogen Indications
  • Warnings and cautions for Prestige V + VEE with Havlogen
  • Direction and dosage information for Prestige V + VEE with Havlogen

Prestige V + VEE with Havlogen

This treatment applies to the following species:
Manufacturer: Intervet/Merck Animal Health

ENCEPHALOMYELITIS - RHINOPNEUMONITIS - INFLUENZA VACCINE, EASTERN & WESTERN & VENEZUELAN, KILLED VIRUS, TETANUS TOXOID

A combination of inactivated, concentrated, adjuvanted, tissue culture origin, equine encephalomyelitis viruses (Eastern, Western and Venezuelan), equine herpesviruses types 1 and 4 (EHV-1 and EHV-4), equine influenza virus type H3N8 strains (EIV A/Equine 2/ Kentucky/93 American, EIV A/Equine 2/Kentucky/02 American and EIV A/Equine 2/Newmarket/2/93 Eurasian) and tetanus toxoid. Intervet serological data suggest influenza cross protection against certain U.S. and European strains, including Kentucky 91, 93, 99, 02, Ohio 03, Newmarket/1/93, Newmarket/2/93, Suffolk 89 and South Africa 03.

Prestige V + VEE with Havlogen Indications

For vaccination of healthy horses, 6 months of age or older, as an aid in the prevention of disease caused by Eastern, Western and Venezuelan encephalomyelitis viruses and tetanus, as an aid in the control of respiratory disease caused by EIV EHV-1 and EHV-4 and as an aid in reduction of virus shedding of EIV and EHV-1. Duration of immunity (DOI) has been shown to be at least 6 months for EIV. Foals nursing immune-dams should be vaccinated when maternal antibody levels will allow active immunization.

DOSE: For primary vaccination aseptically inject 1 mL intramuscularly, repeat with a single dose in 3 - 4 weeks. Annual revaccination is recommended. A booster dose can be administered at more frequent intervals based upon individual horse or farm disease risk assessment or any time epidemic conditions exist or are reported. Consult your veterinarian.

CAUTIONS: Store at 2°-7°C (35°-45°F). Shake well before using. Do not vaccinate within 21 days before slaughter. Inject deep into the muscle only. Local reactions may occur at the injection sites in vaccinates. Systemic reactions may also occur in animals following vaccination. If allergic reaction occurs, treat with epinephrine. Care should be used to avoid injecting your own fingers, hands, or other body parts. Accidental injection can cause serious local reactions. Contact a physician immediately if an accidental injection occurs.

ANTIBIOTIC: Gentamicin.

PRESERVATIVE: Thimerosal.

Adjuvant: Intervet’s Proprietary Technology.

FOR ANIMAL USE ONLY

Intervet Inc., Merck Animal Health, division of Intervet Inc., Omaha, NE 68103, USA

U.S. Vet Lic. No 165A

1 800 521-5767 (USA)

1 866 683-7838 (CAN)

For patent information: http://www.merck.com/product/patent/home.html

 

 

Code

 

10 Doses

10 x 1 mL Syringes with Separate Sterile Needles

030313

145893-02

10 Doses

10 mL

032887

139105-02

NAC No.: 10474142

INTERVET INC., MERCK ANIMAL HEALTH
556 MORRIS AVE., SUMMIT, NJ, 07901
Customer Service:   800-521-5767
Order Desk:   800-648-2118
Technical Service (Companion Animal):   800-224-5318
Technical Service (Livestock):   800-211-3573
Fax:   908-473-5560
Website:   www.merck-animal-health-usa.com
Every effort has been made to ensure the accuracy of the Prestige V + VEE with Havlogen information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the US product label or package insert.

Copyright © 2014 North American Compendiums. Updated: 2014-07-28

(web1)